Next report date
Report period
Q1 2024
EPS estimate
−0.37USD
Revenue estimate
—
−40.33 MUSD
22.85 M
Om Eledon Pharmaceuticals, Inc.
Sektor
Bransch
VD
David-Alexandre C. Gros
Webbplats
Huvudkvarter
Irvine
Employees (FY)
20
Grundat
2004
FIGI
BBG00241S542
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
